Physician profile
Randy Klein
NPI 1265549042
$660.47
in general payments reported to CMS, 2019-2025
11 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.51 · 2023: $150 · 2024: $104 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $166.91 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Pfizer INC. | $120.24 | 2023-2025 | |
| Exact Sciences Corporation | $88.56 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $72.82 | 2019-2024 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $62.19 | 2019-2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $42.88 | 2023 | Mounjaro |
| Novo Nordisk INC | $35.19 | 2019-2025 | Rybelsus, Ozempic |
| Inspire Medical Systems, INC. | $25.42 | 2025 | Inspire |
| Abbvie INC. | $16.67 | 2025 | |
| Sanofi Pasteur INC. | $15.00 | 2019 | |
| Astellas Pharma US INC | $14.59 | 2024 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.